Changes in coagulation and fibrinolysis in the postoperative period immediately after kidney transplantation in patients receiving OKT3 or cyclosporine a as induction therapy

被引:16
作者
Deira, J
Alberca, I
Lerma, JL
Martín, B
Tabernero, JM
机构
[1] Univ Hosp, Serv Nefrol, Salamanca 37007, Spain
[2] Univ Hosp, Hematol Serv, Salamanca 37007, Spain
关键词
renal transplantation; thrombotic risk factors; monoclonal antibody OKT3; cyclosporine A; surgical stress;
D O I
10.1016/S0272-6386(98)70019-8
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Different immunosuppressive agents, in particular OKT3, have been implicated as causative factors in the risk for renal thrombosis in the period immediately after kidney transplantation. Also, in different types of vascular surgery, a state similar to hypercoagulation has been reported. To assess the extent to which OKT3, cyclosporine A (CsA), and surgery itself affect coagulation and fibrinolysis, a study was conducted of 20 patients divided into two groups: group A, 10 patients received OKT3 (first dose during the induction of anesthesia); and group B, 10 patients received CsA (first dose at least 2 hours before transplantation). Basal determinations and determinations at 2, 4, and 24 hours after the induction of anesthesia were made. No differences were found between the groups with respect to the clinical and usual coagulation parameters. The following were studied in both groups: (1) markers of coagulation activity (prekallikrein [PKK] levels and formation of thrombin-antithrombin complexes [TATc]), (2) inhibitors and suppressors of hemostasis (antithrombin III [AT-III] and protein C [PC] activity), (3) markers of fibrinolysis activation (levels of plasminogen [PLG] and of alpha(2)-antiplasmin [(alpha(2)-APL]), and (4) markers of endothelial damage (tissue plasminogen activator [TPA] and thrombomodulin [TMD]), In both groups, an important formation of TATc was observed early, together with a decrease in PKK levels and consumption of both AT-III and PC, which reached their lowest levels at 24 hours. This points to an activation of coagulation through the intrinsic route and a secondary consumption of hemostasis inhibitors, both possibly caused by surgery. A consumption of PLG and alpha(2)-APL was also observed, reflecting stimulation of the fibrinolytic system and a physiological response to the activation of coagulation. A greater release of endothelial TPA was only observed in the patients receiving OKT3 (P < 0.0001), possibly signaling endothelial activation. It is concluded that surgical stress could be the major factor triggering the alterations seen in hemostasis and their possible consequences. (C) 1998 by the National Kidney Foundation, Inc.
引用
收藏
页码:575 / 581
页数:7
相关论文
共 23 条
  • [1] RELEASE OF TUMOR NECROSIS FACTOR, INTERLEUKIN-2, AND GAMMA-INTERFERON IN SERUM AFTER INJECTION OF OKT3 MONOCLONAL-ANTIBODY IN KIDNEY-TRANSPLANT RECIPIENTS
    ABRAMOWICZ, D
    SCHANDENE, L
    GOLDMAN, M
    CRUSIAUX, A
    VEREERSTRAETEN, P
    DEPAUW, L
    WYBRAN, J
    KINNAERT, P
    DUPONT, E
    TOUSSAINT, C
    [J]. TRANSPLANTATION, 1989, 47 (04) : 606 - 608
  • [2] HIGH-DOSE GLUCOCORTICOSTEROIDS INCREASE THE PROCOAGULANT EFFECTS OF OKT3
    ABRAMOWICZ, D
    PRADIER, O
    DEPAUW, L
    KINNAERT, P
    MAT, O
    SURQUIN, M
    DOUTRELEPONT, JM
    VANHERWEGHEM, JL
    CAPEL, P
    VEREERSTRAETEN, P
    GOLDMAN, M
    [J]. KIDNEY INTERNATIONAL, 1994, 46 (06) : 1596 - 1602
  • [3] INDUCTION OF THROMBOSES WITHIN RENAL GRAFTS BY HIGH-DOSE PROPHYLACTIC OKT3
    ABRAMOWICZ, D
    PRADIER, O
    MARCHANT, A
    FLORQUIN, S
    DEPAUW, L
    VEREERSTRAETEN, P
    KINNAERT, P
    VANHERWEGHEM, JL
    GOLDMAN, M
    [J]. LANCET, 1992, 339 (8796) : 777 - 778
  • [4] ARAMOTO H, 1994, INT J CARDIOL, V47, P55
  • [5] CHANDLER WL, 1995, THROMB HAEMOSTASIS, V74, P1293
  • [6] CYCLOSPORINE AND CREMAPHOR MODULATE VON-WILLEBRAND-FACTOR RELEASE FROM CULTURED HUMAN ENDOTHELIAL-CELLS
    COLLINS, P
    WILKIE, M
    RAZAK, K
    ABBOT, S
    HARLEY, S
    BAX, C
    ZAIDI, M
    BLAKE, D
    CUNNINGHAM, J
    NEWLAND, A
    [J]. TRANSPLANTATION, 1993, 56 (05) : 1218 - 1223
  • [7] MAIN GRAFT VESSELS THROMBOSES DUE TO CONVENTIONAL-DOSE OKT3 IN RENAL-TRANSPLANTATION
    GOMEZ, E
    AGUADO, S
    GAGO, E
    ESCALADA, P
    ALVAREZGRANDE, J
    [J]. LANCET, 1992, 339 (8809) : 1612 - 1613
  • [8] KAN J, 1989, JPN J SURG, V19, P262
  • [9] RENAL-TRANSPLANTATION IN CHILDREN AND ADOLESCENTS - THE 1992 ANNUAL-REPORT OF THE NORTH-AMERICAN PEDIATRIC RENAL-TRANSPLANT COOPERATIVE STUDY
    MCENERY, PT
    ALEXANDER, SR
    SULLIVAN, K
    TEJANI, A
    [J]. PEDIATRIC NEPHROLOGY, 1993, 7 (06) : 711 - 720
  • [10] PARMAR MS, 1994, CLIN TRANSPLANT, V8, P120